Literature DB >> 7845041

Medical and surgical management of intracranial aneurysms.

F B Meyer1, A Morita, M R Puumala, D A Nichols.   

Abstract

OBJECTIVE: To examine the medical and surgical aspects of intracranial aneurysms, including the pathogenesis, clinical manifestations, management of subarachnoid hemorrhage (SAH), and indications for surgical intervention.
DESIGN: This review presents the classification of intracranial aneurysms, defines specific aneurysms, and analyzes the Mayo Clinic experience with surgical treatment of cerebral aneurysms.
MATERIAL AND METHODS: Intracranial aneurysms are classified by cause, size, site, and shape. The clinical grading systems for SAH, the most common manifestation, are as follows: modified Botterell, Hunt and Hess, and World Federation of Neurological Surgeons. Surgical options are direct clipping, interventional neuroradiologic treatment, proximal ligation or trapping of aneurysms, and wrapping or coating of aneurysms. Although the timing of surgical intervention after SAH is controversial, it should be based on the clinical grade, site of the aneurysm, and patient's medical condition.
RESULTS: The frequency of intracranial aneurysms is estimated to be 1 to 8% in the general population, and 90% of patients have SAH. After SAH, 8 to 60% of patients die before they get to a hospital. After hospitalization, the mortality rate is 37%, severe disability is 17%, and outcome is favorable in 47%. The current trend for surgical treatment is early after SAH. The Mayo Clinic experience with 1,947 patients who underwent surgical treatment because of aneurysmal SAH or for aneurysmal repair between 1969 and 1990 is as follows: 1,445 had an excellent outcome, 231 had a good outcome, 171 had a poor outcome, and 100 died.
CONCLUSION: Aggressive management can be beneficial for many patients with severe neurologic injury after SAH by preventing rerupture of the aneurysm, attenuating the severity and sequelae of vasospasm, and decreasing the surgical complications.

Entities:  

Mesh:

Year:  1995        PMID: 7845041     DOI: 10.4065/70.2.153

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Absent relationship between the coil-embolization ratio in small aneurysms treated with a single detachable coil and outcomes.

Authors:  James K Goddard; Christopher J Moran; DeWitte T Cross; Colin P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  MR imaging after aneurysmal subarachnoid hemorrhage and surgery: a long-term follow-up study.

Authors:  R P Kivisaari; O Salonen; A Servo; T Autti; J Hernesniemi; J Ohman
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

3.  New Devices Designed to Improve the Long-Term Results of Endovascular Treatment of Intracranial Aneurysms. A Proposition for a Randomized Clinical Trial to Assess their Safety and Efficacy.

Authors:  J Raymond; P Leblanc; M Chagnon; G Gévry; J P Collet; F Guilbert; A Weill; D Roy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

4.  A randomized trial on the safety and efficacy of endovascular treatment of unruptured intracranial aneurysms is feasible.

Authors:  J Raymond; M Chagnon; J P Collet; F Guilbert; A Weill; D Roy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

5.  Measurement of quantifiable parameters by time-density curves in the elastase-induced aneurysm model: first results in the comparison of a flow diverter and a conventional aneurysm stent.

Authors:  Tobias Struffert; Sabine Ott; Markus Kowarschik; Frederik Bender; Edyta Adamek; Tobias Engelhorn; Philipp Gölitz; Stefan Lang; Charles M Strother; Arnd Doerfler
Journal:  Eur Radiol       Date:  2012-08-16       Impact factor: 5.315

Review 6.  Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options.

Authors:  G J Kaptain; G Lanzino; N F Kassell
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

7.  A Randomized Trial Comparing Platinum and Hydrogel-coated Coils in Patients Prone to Recurrence after Endovascular Treatment (The PRET Trial).

Authors:  J Raymond; D Roy; P M White; D Fiorella; R Chapot; S Bracard; D F Kallmes
Journal:  Interv Neuroradiol       Date:  2008-05-12       Impact factor: 1.610

8.  Unruptured intracranial aneurysms and the Trial on Endovascular Aneurysm Management (TEAM): The principles behind the protocol.

Authors:  Jean Raymond; Daniel Roy; Alain Weill; François Guilbert; Thanh Nguyen; Andrew J Molyneux; Allan J Fox; S Claiborne Johnston; Jean-Paul Collet; Isabelle Rouleau
Journal:  J Vasc Interv Neurol       Date:  2008-01

9.  Angiographic quantification of contrast medium washout from cerebral aneurysms after stent placement.

Authors:  Chander Sadasivan; Baruch B Lieber; Matthew J Gounis; Demetrius K Lopes; L N Hopkins
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

10.  Antiplatelet therapy for prevention of thromboembolic complications associated with coil embolization of unruptured cerebral aneurysms.

Authors:  Yasushi Matsumoto; Ryushi Kondo; Yasuhiko Matsumori; Hiroaki Shimizu; Akira Takahashi; Teiji Tominaga
Journal:  Drugs R D       Date:  2012-03-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.